A pre-clinical study in mice has exploited the CRISPR gene editing technique to engineer cancer cells that hunt down and attack their tumor of origin, improving overall survival rates.

See the source article by following the link below:
A pre-clinical study in mice has exploited the CRISPR gene editing technique to engineer cancer cells that hunt down and attack their tumor of origin, improving overall survival rates.